General_NN
insurance_NN
companies_NN
will_PRMD [SPAU]
soon_TIME
offer_VB
health_NN
insurance_NN
policies_NN
to_TO
cover_VB
treatment_NOMZ
of_PIN
mental_JJ
illness_NOMZ
._.
Asking_VBG [SUAV]
insurance_NN
companies_NN
to_TO
comply_VB
with_PIN
the_DT
Mental_NN
Healthcare_NN
Act_NN
2017_CD
with_PIN
immediate_JJ
effect_NN
,_,
the_DT
Insurance_NN
Regulatory_NN
and_PHC
Development_NOMZ
Authority_NOMZ
of_PIN
India_NN
-LRB-_-LRB-
Irdai_NN
-RRB-_-RRB-
on_PIN
Thursday_NN
,_,
said_VBD [PUBV]
,_,
``_``
Every_QUAN
insurer_NN
shall_PRMD
make_VB
provision_NN
for_PIN
medical_JJ
insurance_NN
for_PIN
treatment_NOMZ
of_PIN
mental_JJ
illness_NOMZ
on_PIN
the_DT
same_JJ
basis_NN
as_IN
is_VPRT [BEMA]
available_PRED
for_PIN
treatment_NOMZ
of_PIN
physical_JJ
illness_NOMZ
._.
''_''
The_DT
draft_NN
version_NN
of_PIN
the_DT
Mental_NN
Healthcare_NN
Act_NN
,_,
issued_VBN
last_JJ
year_NN
,_,
had_VBD [PEAS]
asked_VBN [SUAV]
insurance_NN
companies_NN
not_XX0
to_PIN
discriminate_JJ
between_PIN
patients_NN
suffering_VBG [WZPRES]
from_PIN
mental_JJ
ailments_NOMZ
._.
The_DT
act_NN
came_VBD
into_PIN
force_NN
in_PIN
May_POMD
2018_CD
._.
Irdai_NN
's_POS
guideline_NN
is_VPRT
following_VBG
this_DEMP
._.
While_OSUB
there_EX
is_VPRT
a_DT
genuine_JJ
need_NN
to_TO
cover_VB
mental_JJ
ailments_NOMZ
,_,
there_EX
are_VPRT
issues_NN
and_CC
the_DT
existing_VBG
product_NN
structures_NN
may_POMD
not_XX0
allow_VB [SUAV]
it_PIT
,_,
said_VBD [PUBV]
insurance_NN
company_NN
officials_NN
._.
According_VBG [PRESP]
to_PIN
Nikhil_NN
Apte_NN
,_,
chief_JJ
product_NN
officer-product_NN
factory_NN
-LRB-_-LRB-
health_NN
-RRB-_-RRB-
,_,
Royal_NN
Sundaram_NN
General_NN
Insurance_NN
,_,
one_CD
of_PIN
the_DT
challenge_NN
is_VPRT
that_DEMO
a_EMPH
lot_NULL
of_PIN
treatment_NOMZ
for_PIN
mental_JJ
ailments_NOMZ
is_VPRT [BEMA]
Out_PIN
Patient_NN
Department_NOMZ
treatment_NOMZ
._.
In-patient_JJ
treatment_NOMZ
is_VPRT [BEMA]
in_PIN
very_AMP
serious_JJ
cases_NN
._.
This_DEMP
makes_VPRT
it_PIT
tough_JJ
for_PIN
companies_NN
to_TO
structure_VB
the_DT
product_NN
._.
Insurance_NN
companies_NN
will_PRMD
have_VB
to_TO
make_VB
modifications_NOMZ
in_PIN
existing_VBG
product_NN
features_NN
to_TO
cover_VB
it_PIT
._.
``_``
The_DT
need_NN
is_VPRT [BEMA]
genuine_PRED
._.
But_CC
if_COND
there_EX
is_VPRT
non-disclosure_NN
of_PIN
the_DT
disease_NN
by_PIN
the_DT
customer_NN
,_,
then_RB
it_PIT
could_POMD
lead_VB
to_PIN
anti-selection_JJ
._.
We_FPP1
do_EMPH
underwriting_VBG
basis_NN
age_NN
,_,
sum_NN
insured_VBN [PRIV]
and_CC
declaration_NOMZ
._.
We_FPP1
take_VPRT
blood_NN
,_,
urine_NN
sample_NN
,_,
electrocardiogram_NN
-LRB-_-LRB-
ECG_NN
-RRB-_-RRB-
,_,
etc._FW
._.
But_CC
an_DT
ailment_NOMZ
like_IN
schizophrenia_NN
will_PRMD
not_XX0
be_VB [BEMA]
evident_PRED
to_PIN
the_DT
insurer_NN
,_,
''_''
he_TPP3
said_VBD [PUBV]
._.
One_CD
way_NN
out_PIN
could_POMD
be_VB
to_TO
set_VB
sub-limits_NN
for_PIN
such_JJ
ailments_NOMZ
and_CC
increase_VB
the_DT
sub-limits_NN
,_,
gradually_RB
or_CC
offer_VB
coverage_NN
after_IN
a_DT
certain_JJ
number_NN
of_PIN
years_NN
,_,
he_TPP3
added_VBD [PUBV]
._.
